Relevant bibliographies by topics / Heart Diseases Treatment Victoria

Academic literature on the topic 'Heart Diseases Treatment Victoria'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Heart Diseases Treatment Victoria.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Heart Diseases Treatment Victoria"

1

Funder, Jordan L., Kelly-Ann Bowles, and Linda J. Ross. "Diagnostic ability of a computer algorithm to identify prehospital STEMI." Journal of Paramedic Practice 14, no. 9 (September 2, 2022): 366–72. http://dx.doi.org/10.12968/jpar.2022.14.9.366.

Full text
Abstract:
Background: Acute myocardial infarction (AMI) accounts for 43% of deaths related to ischaemic heart disease, with ST-segment elevation myocardial infarction (STEMI) accounting for 25%–40% of all AMI presentations. Given the impact of these diseases, there is a strong prehospital focus on early identification, treatment and transport of patients with acute coronary syndrome. The main aim of the STEMI system of care is to reduce the time to reperfusion of the myocardium, thereby improving morbidity and mortality rates. Therefore, the identification of STEMI by paramedics can have a dramatic effect on patients' long-term health outcomes. Ambulance Victoria paramedics play a crucial role in the care provided to AMI patients across the state, with the assistance of a computer-automated interpretation of 12-lead electrocardiograms (ECGs) to aid STEMI identification. Objectives: This study's objective is to analyse the diagnostic capability of the computer-automated interpretation to diagnose STEMI in the out-of-hospital setting. Methods: Quantitative data from January 2018 to December 2019 was sourced from the Victorian Ambulance STEMI Quality Initiative. These data were periodically matched with hospital outcome and diagnosis data from the Victorian Cardiac Outcomes Registry to compare provisional paramedic diagnoses with the final hospital diagnoses. Results: Of the 5269 cases of suspected STEMI, 765 (14.5%) could be matched with outcome data. Of these 765 cases, 88.9% were correctly identified as STEMI. The remaining 10% were categorised as either non-STEMI or unstable angina. No data were available for 1.1%. Conclusions: The diagnostic capability of the Zoll Inovise 12L interpretive algorithm to diagnose STEMI in the out-of-hospital setting appears safe and feasible. However, because of limited data matching paramedic findings with patient outcomes in hospital, no hard conclusions can be drawn. Furthermore, there is no way to ascertain how many false positives the Zoll monitor is interpreting. Further investigation is required to assess the true diagnostic capability of the Zoll Inovise 12L interpretive algorithm.
APA, Harvard, Vancouver, ISO, and other styles
2

Jones, Julia L., Natalie G. Lumsden, Koen Simons, Anis Ta'eed, Maximilian P. de Courten, Tissa Wijeratne, Nicholas Cox, et al. "Using electronic medical record data to assess chronic kidney disease, type 2 diabetes and cardiovascular disease testing, recognition and management as documented in Australian general practice: a cross-sectional analysis." Family Medicine and Community Health 10, no. 1 (February 2022): e001006. http://dx.doi.org/10.1136/fmch-2021-001006.

Full text
Abstract:
ObjectivesTo evaluate the capacity of general practice (GP) electronic medical record (EMR) data to assess risk factor detection, disease diagnostic testing, diagnosis, monitoring and pharmacotherapy for the interrelated chronic vascular diseases—chronic kidney disease (CKD), type 2 diabetes (T2D) and cardiovascular disease.DesignCross-sectional analysis of data extracted on a single date for each practice between 12 April 2017 and 18 April 2017 incorporating data from any time on or before data extraction, using baseline data from the Chronic Disease early detection and Improved Management in PrimAry Care ProjecT. Deidentified data were extracted from GP EMRs using the Pen Computer Systems Clinical Audit Tool and descriptive statistics used to describe the study population.SettingEight GPs in Victoria, Australia.ParticipantsPatients were ≥18 years and attended GP ≥3 times within 24 months. 37 946 patients were included.ResultsRisk factor and disease testing/monitoring/treatment were assessed as per Australian guidelines (or US guidelines if none available), with guidelines simplified due to limitations in data availability where required. Risk factor assessment in those requiring it: 30% of patients had body mass index and 46% blood pressure within guideline recommended timeframes. Diagnostic testing in at-risk population: 17% had diagnostic testing as per recommendations for CKD and 37% for T2D. Possible undiagnosed disease: Pathology tests indicating possible disease with no diagnosis already coded were present in 6.7% for CKD, 1.6% for T2D and 0.33% familial hypercholesterolaemia. Overall prevalence: Coded diagnoses were recorded in 3.8% for CKD, 6.6% for T2D, 4.2% for ischaemic heart disease, 1% for heart failure, 1.7% for ischaemic stroke, 0.46% for peripheral vascular disease, 0.06% for familial hypercholesterolaemia and 2% for atrial fibrillation. Pharmaceutical prescriptions: the proportion of patients prescribed guideline-recommended medications ranged from 44% (beta blockers for patients with ischaemic heart disease) to 78% (antiplatelets or anticoagulants for patients with ischaemic stroke).ConclusionsUsing GP EMR data, this study identified recorded diagnoses of chronic vascular diseases generally similar to, or higher than, reported national prevalence. It suggested low levels of extractable documented risk factor assessments, diagnostic testing in those at risk and prescription of guideline-recommended pharmacotherapy for some conditions. These baseline data highlight the utility of GP EMR data for potential use in epidemiological studies and by individual practices to guide targeted quality improvement. It also highlighted some of the challenges of using GP EMR data.
APA, Harvard, Vancouver, ISO, and other styles
3

Ward, D. "Treatment of heart diseases." International Journal of Cardiology 42, no. 2 (December 1993): 183–84. http://dx.doi.org/10.1016/0167-5273(93)90091-t.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zoneraich, Samuel. "Treatment of Heart Diseases." JAMA: The Journal of the American Medical Association 270, no. 17 (November 3, 1993): 2100. http://dx.doi.org/10.1001/jama.1993.03510170090040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zbârcea, Cristina Elena, Cristina Daniela Marineci, Oana-Cristina Şeremet, and Simona Negreş. "Pharmacological treatment of ischemic heart diseases." Farmacist.ro 1, no. 186 (2019): 40. http://dx.doi.org/10.26416/farm.186.1.2019.2256.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Falster, Kathleen, Linda Gelgor, Ansari Shaik, Iryna Zablotska, Garrett Prestage, Jeffrey Grierson, Rachel Thorpe, et al. "Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment." Sexual Health 5, no. 2 (2008): 141. http://dx.doi.org/10.1071/sh07082.

Full text
Abstract:
Objectives: To determine if there were any differences in antiretroviral treatment (ART) use across the three eastern states of Australia, New South Wales (NSW), Victoria and Queensland, during the period 1997 to 2006. Methods: We used data from a clinic-based cohort, the Australian HIV Observational Database (AHOD), to determine the proportion of HIV-infected patients on ART in selected clinics in each state and the proportion of treated patients with an undetectable viral load. Data from the national Highly Specialised Drugs program and AHOD were used to estimate total numbers of individuals on ART and the proportion of individuals living with HIV on ART nationally and by state. Data from the HIV Futures Survey and the Gay Community Periodic Survey were used to determine the proportion of community-based men who have sex with men on ART. The proportion of patients with primary HIV infection (PHI) who commenced ART within 1 year of diagnosis was obtained from the Acute Infection and Early Disease Research Program (AIEDRP) CORE01 protocol and Primary HIV and Early Disease Research: Australian Cohort (PHAEDRA) cohorts. Results: We estimated that the numbers of individuals on ART increased from 3181 to 4553 in NSW, 1309 to 1926 in Victoria and 809 to 1615 in Queensland between 2000 and 2006. However, these numbers may reflect a lower proportion of individuals living with HIV on ART in NSW compared with the other states (37% compared with 49 and 55% in 2000). We found similar proportions of HIV-positive men who have sex with men participants were on ART in all three states over the study period in the clinic-based AHOD cohort (81–92%) and two large, community-based surveys in Australia (69–85% and 49–83%). Similar proportions of treated patients had an undetectable viral load across the three states, with a consistently increasing trend over time observed in all states. We found that more PHI patients commenced treatment in the first year following HIV diagnosis in NSW compared with Victoria; however, the sample size was very small. Conclusions: For the most part, patterns of ART use were similar across NSW, Victoria and Queensland using a range of available data from cohort studies, community surveys and national prescription databases in Australia. However, there may be a lower proportion of individuals living with HIV on ART in NSW compared with the other states, and there is some indication of a more aggressive treatment approach with PHI patients in NSW compared with Victoria.
APA, Harvard, Vancouver, ISO, and other styles
7

Jovanovic, Ida, Vojislav Parezanovic, Slobodan Ilic, Djordje Hercog, Milan Vucicevic, Milan Djukic, Irena Vulicevic, et al. "Treatment of cyanotic heart diseases in children." Srpski arhiv za celokupno lekarstvo 132, suppl. 1 (2004): 9–13. http://dx.doi.org/10.2298/sarh04s1009j.

Full text
Abstract:
Cyanotic heart diseases are relatively rare, but they are severe and heterogeneous congenital heart diseases, which require complex surgery. Development of different advanced surgical procedures, such as arterial switch operation (ASO), Fontan and its modifications, Norwood etc. operations, as well as better perioperative care significantly improved survival rate and quality of life of these children. The study group included 308 children treated for cyanotic heart disease in Yugoslavia, in the period January 2000 to July 2004. Some of them (239, 77.6%) were treated at the University Children?s Hospital in Belgrade, and others (69, 22.4%) in different institutions abroad. The age of the operated patients varied between 1 day and 19 years (median 12 months). The patients (pts) were divided into four groups, according to the disease and type of the operation. In the whole group of 308 patients treated due to cyanotic heart disease, there were 232 (75.3%) cases with open heart surgery and 76 (24.7%) with closed procedures. The mortality rate was significantly different between disease/operation groups, and age groups. Average mortality rates differed from 11.8% for palliative procedures to 12.5% for complete corrections. Mortality rate and achieved surgical results in treatment of chil?dren with cyanotic heart diseases were significantly worse than those published by leading cardiac surgery centers in the world. However, there is a clear tendency in introducing new surgical procedures, lowering the age at which the operation is done and decreasing the mortality rates.
APA, Harvard, Vancouver, ISO, and other styles
8

KHAN, HAMZULLAH. "RHEUMATIC HEART DISEASES." Professional Medical Journal 16, no. 01 (March 10, 2009): 100–104. http://dx.doi.org/10.29309/tpmj/2009.16.01.2990.

Full text
Abstract:
O b j e c t i v e s : To determine the frequency of rheumatic heart diseases in a hospital based study in Peshawar. D e s i g n : Across sectional observational. Setting: Cardiology department, Lady-Reading Hospital Peshawar. Period: From July 2005 to July 2006.M e t h o d : Relevant in formations were recorded from patients and treatment chart of the patients, on a questionnaire designed in accordancewith the objectives of the study. Results: A total of 88 patients with established diagnosis of rheumatic hear diseases (RHD) were randomlyselected. Out of total 70.45% were females and 29.54% males, with males to females ratio of 1:2.38. The age range of the patients wasfrom 8 years to 64 years with mean age of 47 years. The mode of age was 35 years. The frequency of rheumatic heart diseases was: MitralStenosis 13.63%, Mitral Regurgitation 60.22%, Mitral Stenosis /Mitral Regurgitation 21.59%, Aortic Stenosis/Aortic Regurgitation 2.27%,Aortic Stenosis 1.13% and Tricuspid Valve Stenosis 1.13%. We observed that RHD were more common in lower social class people(42.04%) with income less than 5000/month. C o n c l u s i o n : In our setup RHD are more common in female gender and especially in theyounger age, Mitral Stenosis was recorded as major type of RHD in our patients.
APA, Harvard, Vancouver, ISO, and other styles
9

Wiewiórka, Łukasz, Jarosław Trębacz, Andrzej Gackowski, Robert Sobczyński, Maciej Stąpór, Janusz Konstanty-Kalandyk, Paweł Kleczyński, Robert Musiał, Bogusław Kapelak, and Jacek Legutko. "Complete transcatheter treatment of multiple heart valve diseases." Kardiologia Polska 79, no. 3 (March 25, 2021): 350–51. http://dx.doi.org/10.33963/kp.15799.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nakamura, C. "Valvular heart diseases. Surgical treatment of infective endocarditis." Japanese Journal of Cardiovascular Surgery 20, no. 5 (1991): 946–48. http://dx.doi.org/10.4326/jjcvs.20.946.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Heart Diseases Treatment Victoria"

1

Cho, Jinsoo. "Velocity-based cardiac segmentation and motion-tracking." Diss., Available online, Georgia Institute of Technology, 2004:, 2003. http://etd.gatech.edu/theses/available/etd-04082004-180106/unrestricted/cho%5Fjinsoo%5F200312%5Fphd.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lai, Tik-man Clare, and 賴迪雯. "Circulating biomarkers and right ventricular function in adolescents and young adults with congenital heart disease." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/197541.

Full text
Abstract:
The population of adolescent and adults with congenital heart disease (CHD) has grown rapidly. Right ventricular (RV) dysfunction remains an important issue of concern in the long-term follow up of these patients. While circulating biomarkers have shown promise in the assessment and monitoring of adult patients with left heart diseases, little is known of the role of biomarkers in reflecting RV performance in CHD patients. Emerging circulating biomarkers that reflect underlying pathophysiologic processes have gained increasing attention. These include inflammatory cytokines namely tumour necrosis factor (TNF)-α, a biomarker of apoptosis annexin A5 (AnxA5), carboxy-terminal propeptide of type I procollagen (PICP) and amino-terminal propeptide of type III procollagen (PIIINP) that reflects collagen synthesis and turnover, low circulating levels of cardiac troponin T as detected by highly sensitive assay (hs-cTnT) that may reflect subclinical myocardial injury, and microRNAs found to be involved in cardiac remodeling. The studies in this thesis aimed to test the hypothesis that circulating biomarkers may be altered in patients with volume-overloaded right ventricles after repair of tetralogy (TOF) and pressure-overloaded right ventricles after atrial switch operation for complete transposition of the great arteries (TGA), and are related to indices of RV function. In patients after TOF repair, increased circulating PICP and PIIINP levels were associated with worse subpulmonary RV and left ventricular (LV) function. In particular, these propeptides correlated positively with LV mechanical dyssynchrony, implicating a possible role of increased collagen synthesis in its pathogenesis. Increased plasma levels of hs-cTnT were further found in 30% of female, but not male patients. Female patients with elevated hs-cTnT levels compared to those without had greater RV volumes and LV mechanical dyssynchrony. Independent correlates of hs-cTnT in patients as determined from multivariate analysis were sex and RV ejection fraction. MicroRNA profiling following validation confirmed alteration of circulating levels of miR-99b and miR-766 in repaired TOF patients, a pattern distinct from that reported for left heart diseases. The miRNA expression was, however, not related to the cardiac functional indices. Patients after atrial repair for TGA had significantly higher circulating AnxA5 and TNF-αlevels, but similar PICP, PIIINP levels, compared with controls. Elevated AnxA5 level was associated with impaired systemic RV myocardial deformation, increased subpulmonary ventricular eccentricity, and increased TNF-αlevel. Elevation of hs-cTnT is found in 39% of the patients. The positive correlation between hs-cTnT level and systemic RV volume may suggest a role of hs-cTnT in reflecting RV remodeling. Circulating microRNA expression profiling and further validation identified 11 upregulated microRNAs (miR-16, miR-106a, miR-144*, miR-18a, miR-25, miR-451, miR-486-3p, miR-486-5p, miR-505*, let-7e and miR-93). Among them, miR-18a and miR-486-5p correlated negatively with systemic ventricular myocardial acceleration during isovolumic contraction, a relatively-load independent measure of systemic RV contractility. To conclude, these biomarkers reflect in varying extent the structural, functional, biological alteration of the subpulmonary and systemic right ventricles of the CHD patients late after surgical repair. These data may provide new perspectives in the understanding of progressive RV dysfunction in the adult CHD population and hopefully shed more lights on novel therapeutic interventions.
published_or_final_version
Paediatrics and Adolescent Medicine
Doctoral
Doctor of Philosophy
APA, Harvard, Vancouver, ISO, and other styles
3

Broderick, Daniel J. "Mitral valve prolapse syndrome : a proposed treatment through respiratory rebalancing." Virtual Press, 1996. http://liblink.bsu.edu/uhtbin/catkey/1027110.

Full text
Abstract:
Mitral Valve Prolapse Syndrome (MVPS) is a benign psychosomatic cardiac condition that can severely impair one's quality of life. Symptoms targeted in this study include, atypical chest pain, palpitations, anxiety, panic, and shortness of breath.This study was undertaken to examine the effects of a diaphragmatic breathing intervention on the symptoms and underlying mechanism of dysautonomia in a small group of symptomatic females with MVPS. The intervention was based on both yoga theory and cardiorespiratory empirical studies.Seven of eight participant's completed the nine week study using a single subject multiple baseline design across subjects. Participant's began a respiratory retraining intervention, in a weekly staggered pair start, after the first week of baseline measurement. Respiratory training consisted of a four week training in diaphragmatic breathing with home practice three times a day.Autonomic, behavioral, and cognitive systems were assessed. Dependent measures included State and Trait Anxiety, Anxiety Sensitivity, a Symptom Checklist, and Respiratory Sinus Arrhythmia (RSA). RSA is a current noninvasive measure of parasympathetic tone. Data on thoracic and abdominal respiratory predominance, respiration rate, diet, exercise, and adherence were also gathered.Data were analyzed via visual inspection of trends and phase average changes. Treatment effect sizes were calculated for standardized measures to indicate the meaningfulness of change.Two of the seven participants demonstrated a decrease in total symptom frequencies over the course of intervention. One participant demonstrated a weekly progression of lowered state anxiety scores from baseline through intervention. In terms of phase averages, three participants showed a lowering of state anxiety. All seven participants demonstrated lowered trait anxiety scores from pre to post intervention. Two of the seven participants demonstrated a meaningful pre to post intervention decrease in anxiety sensitivity. Respiratory training was effective in stabilizing abdominal respiration. Results regarding vagal tone could not be determined due to unreliable ECG data.In general, results were poor with several inconsistencies. Adherence rates were low and it did not appear that a therapeutic level of change in respiration rate was achieved. Controlling respiration rate may be a critical factor in the therapeutic effectiveness of respiratory retraining interventions.
Department of Counseling Psychology and Guidance Services
APA, Harvard, Vancouver, ISO, and other styles
4

Lam, Lap-fung, and 林立峰. "Flow cytometric analysis of intra-platelet VASP for evaluation of clopidogrel resistance in ischemic heart disease patients undergoingpercutaneous coronary intervention." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48421200.

Full text
Abstract:
Ischemic heart disease (IHD) is the most common cause of death around the world. The underlying cause of IHD is myocardial ischemia as a result of progressive narrowing of coronary arteries due to atherosclerosis with potential thrombotic complications mediated by platelets. In addition to the role in hemostasis, platelets are increasingly recognized as an important mediator in this atherothrombotic disease. Basic management of IHD lies on medical therapy and coronary revascularization procedures. Percutaneous coronary intervention (PCI) is a commonly used revascularization procedure in the treatment of IHD especially for relief and reduction of symptoms. On the other hand, antiplatelet therapy is often administrated to patients undergoing PCI in an attempt to prevent major adverse cardiac events (MACE) following the procedures. However not all patients respond to the same degree of the antiplatelet therapy and some still develop MACE or stent thrombosis in the presence of the treatment with antiplatelet drugs. Recently a flow cytometric-based assay has been developed to monitor the effect of the antiplatelet drug, particularly the P2Y12 receptor antagonist, in patients treated with this kind of drug. This assay measures the activity of platelets as platelet reactivity index (PRI) based on the phosphorylation state of an intracellular platelet protein called vasodilator stimulated phosphoprotein (VASP). The measured value of PRI is inversely related to the response of patient to the antiplatelet drug. In this study, the response of patients to the P2Y12 receptor antagonist Clopidogrel was investigated following PCI. The PRI of patients was found to be significantly lower than normal subjects without taking this drug, indicating the therapeutic effect of this drug on the patients. However nearly one-third of patients (17 out of 59) studied were found to be non-responsive to clopidogrel treatment based on a cut-off established in this study for classifying patients into responders or non-responders. Furthermore, significant difference between the two types of stents used in PCI procedure, namely bare metal stent (BMS) and drug eluting stent (DES), was observed in the study. Patients receiving DES had nearly three times higher percentage of being non-responsive to clopidogrel than the BMS counterpart (45% vs. 16%, p<0.028). This study provides evidence that DES may be implicated in the non-responsiveness or drug resistance of clopidogrel in patient undergoing PCI.
published_or_final_version
Pathology
Master
Master of Medical Sciences
APA, Harvard, Vancouver, ISO, and other styles
5

Zhang, Yuelin, and 張月林. "Mesenchymal stem cells derived from pluripotent stem cells for cardiovascular repair and regeneration." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/196438.

Full text
Abstract:
Despite major advances in pharmacological and surgical treatments of cardiovascular diseases (CVDs), clinical outcomes of patients with severe CVDs remain very poor. Most of medication and interventions currently available are only playing roles of preventing further damage to myocardium, declining the risk of on-going cardiovascular events, lifting the cardiac pumping efficiency and lower early mortality rates, none of these treatments can regenerate or repair damaged cardiac tissue or restore heart function. As a result, several new strategies have been explored to overcome limitations of current therapeutic approaches. One prospective is to replace dead cardiac vascular cells with young and green cells to repair or regenerate damaged heart myocardium. Several types of stem cells, including bone marrow hematopoietic stem cells, mesenchymal stem cells (MSCs), embryonic stem cell (ESCs)and induced pluripotent stem cells (iPSCs),have been tested as the candidates for treatment of CVDs. Among a myriad of types of stem cells, bone marrow derived MSCs(BM-MSCs) has received great attention based on several unique properties such as easy isolation and expansion, stable genetic background and low immunogenicity. However, the therapeutic efficacy of BM-MSCs derived from aging or diseased donors is impaired. The differentiation potential of BM-MSCs is gradually reduced with the increased culture time. Thus, it is urgent to identify some novel alternative sources for MSCs. Moreover, the potential mechanisms of MSCs therapy have not been understood totally. This thesis is designed to investigate the therapeutic efficacy and potential mechanisms of several novel types of MSCs, including hESC-MSCs and hiPSC-MSCs and Rap1-/--BM-MSCson several types of CVDs, including pulmonary arterial hypertension (PAH), dilated cardiomyopathy (DCM)and myocardial infarction (MI). In Chapter 4, it disclosed that hESC-MSCs have a better therapeutic efficacy than BM-MSCs in attenuation of PAH induced by monocrotaline in mice. The greater therapeutic potential of hESC-MSCs on PAH was not only attributed to the higher capacity of differentiation into de-novo vascular cells, but also attributed to higher cell survival rate and greater paracrine effects post-transplantation. In Chapter 5, it demonstrated that compared with BM-MSCs, iPSC-MSCs have a better therapeutic effect on doxorubicin-induced cardiomyopathy. Several potential mechanisms of action were involved in iPSC-MSCs-based therapy for cardiomyopathy. It demonstrated that iPSC-MSCs transplantation not only attenuated the generation of reactive oxygen species(ROS)and the level of inflammation, but also restored depletion of cardiac progenitor cells and promoted endogenous myocardial regeneration against doxorubicin induced cardiomyopathy. Moreover, mitochondrial transfer and paracrine actions of iPSC-MSCs played critical roles in the rescue for doxorubicin-induced cardiomyopathy. In Chapter 6, it uncovered that compared with wild type BM-MSCs,Rap1-/--BM-MSCs transplantation achieved a better benefit to MI induced by ligation of left anterior descending (LAD)coronary artery. Rap1-mediated NF-κB activity plays a key role in regulation MSCscytokine secretion profiles. The absence of Rap1 in MSCs leads to reduced pro-inflammatory cytokines secretion and enhanced MSCs survival capacity, thus yielding a better therapeutic efficacy. In conclusion, findings presented in this thesis provide important new insights regarding different novel types of MSCs, including those derived from ESC and iPSC. They have distinct mechanisms of action from BM-MSCs and provide superior therapeutic efficacy in various form of severe CVDs, including PAH and DCM. The safety and efficacy of these novel types of MSCs for treatment of CVDs deserve further investigations.
published_or_final_version
Medicine
Doctoral
Doctor of Philosophy
APA, Harvard, Vancouver, ISO, and other styles
6

Green, Kerrie L. "A descriptive analysis of cardiac rehabilitation education programs." Virtual Press, 2000. http://liblink.bsu.edu/uhtbin/catkey/1177976.

Full text
Abstract:
The purpose of this research was to obtain information on the content of education within cardiac rehabilitation programs, methods of administering education, what the barriers are to providing education and which professionals administer education.To reach this goal, a questionnaire was modified from a previous study and a pilot study was undertaken to establish reliability of the questionnaire. The questionnaire was then sent to a sample of 100 directors of cardiac rehabilitation programs belonging to The American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). The questionnaire focused on 13 established areas of education within cardiac rehabilitation programs.Once the questionnaires were completed, the information was transferred to a table format based upon the 13 content areas. The following conclusions were drawn from the research and the data gathered: 11 of the 13 content areas are offered at least 84% of the time, the major barriers for the 13 content areas were lack of time and lack of interest on the patient's behalf, the most frequent methods of education for all 13 content areas were individual education, print materials, and group education, and the primary educator overall for all 13 content areas was the nurse followed by the exercise physiologist and dietitian/nutritionist.
Department of Physiology and Health Science
APA, Harvard, Vancouver, ISO, and other styles
7

McKee, Kevin J. "The doctor, the patient and the illness : an examination of the psychology of heart disease." Thesis, University of Stirling, 1986. http://hdl.handle.net/1893/22872.

Full text
Abstract:
The aims of the present study were threefold: firstly, to further the understanding of the psychological response to heart disease; secondly, to consider the differences in the ways in which doctors and patients perceive heart disease; and thirdly, to consider how the doctor, patient, and condition interact within the illness process over a period of time. The nature of coronary heart disease (CHD) was considered, and the influence of psychological variables in CHD was discussed. Psychological factors in illness were examined, with particular emphasis on health beliefs, illness behaviour, compliance, and the doctor-patient relationship. Conclusions were drawn that to understand the illness process in heart disease, doctor, patient, and condition must be considered together, in an interactional framework. Two pilot studies were performed. The first study found that heart patients' health beliefs differed from a normal population. The second pilot study, with raised cholesterol patients, suggested the existence of five major components of the illness process: illness perception, illness effect, health orientation, doctor-patient relationship, and compliance. The main study considered groups of heart and cholesterol patients (experimental groups) and a group of general outpatients (control group), over a four-to-six month period. Patients were interviewed and given a questionnaire concerning their feelings regarding their condition. Doctors and judges also completed similar questionnaires. Results indicate that cholesterol patients rate superior coping to the other groups, and both experimental groups were higher than controls with regard to patient understanding, responsibility for health, and communication with doctor. Findings suggests alterations should be made in current conceptualization of illness behaviour. and that patient and doctor assessment of condition severity were found to be unrelated to illness behaviour. Doctor and patient perception of patient behaviour were found to be discrepant. Modifications in the treatment of heart and cholesterol patients are suggested.
APA, Harvard, Vancouver, ISO, and other styles
8

Čibiras, Sigitas Vladas. "Methods of interventional pediatric cardiology in treatment of congenital heart diseases: immediate and long-term results." Doctoral thesis, Lithuanian Academic Libraries Network (LABT), 2010. http://vddb.laba.lt/obj/LT-eLABa-0001:E.02~2010~D_20100204_100248-32962.

Full text
Abstract:
Objective - to assess possibilities and specific characteristics of pediatric cardiology in treatment of congenital heart diseases (CHD), to evaluate efficacy of curative per-catheter procedures by means of analysis of immediate and long-term results. Retrospective study. The data of 422 patients who underwent 467 CHD palliative-curative procedures during the period since 1971 till 2007 were analyzed. It was postulated that balloon atrial septostomy resulted in statistically significant increase of atrial septal defect, increase of arterial blood oxygen saturation and decrease of interatrial preasure gradient (PG). Balloon pulmonary valvulotomy (BPV) is one of the most common curative procedures; this procedure has an effect of marked decrease of pressure gradient between the right ventricle and right atrium; development of pulmonary artery valve insufficiency is the most common complication of this procedure. The long - term results of BPV are less positive when higher PG prior the procedure is present and residual PG after the procedure is 36mmHg and higher. It was postulated, that closure of small (less than 3 mm) persistent ductus arteriosus using Cook coils may compete with surgical treatment successfully. It was stated, that the efficacy of balloon angioplasties of aorta, caval veins and pulmonary artery branches is transient; treatment using stents is more effective. It was postulated, that closure of congenital and postsurgical anomalies connections using coils is... [to full text]
Disertacijos objektas yra nustatyti intervencinės pediatrinės kardiologijos galimybes ir ypatumus, gydant įgimtas širdies ydas (ĮŠY), įvertinti gydomųjų perkateterinių procedūrų efektingumą, remiantis ankstyvųjų ir vėlyvųjų rezultatų analize. Tai retrospektyvus tyrimas. Analizuoti 422 ligonių duomenys, kuriems 1971 - 2007 m. buvo atliekamos 467 įgimtų širdies ydų paliatyvinės - gydomosios procedūros. Nustatyta, kad po balioninės tarpprieširdinės pertvaros septostomijos, statistiškai reikšmingai padidėja prieširdžių pertvaros defektas, didėja arterinio kraujo įsotinimas deguonimi ir mažėja spaudimų skirtumas (SS) tarp prieširdžių. Balioninė plaučių arterijos valvuloplastika (BPV) yra viena iš dažniausiai taikomų gydomųjų procedūrų, jos efektas – ryškus SS tarp dešiniojo skilvelio ir plaučių arterijos (PA) sumažėjimas, o pagrindinė komplikacija – PA vožtuvo nesandarumo vystymasis. BPV vėlyvieji rezultatai blogesni, kai yra didelis SS prieš procedūrą, o po procedūros liekamasis SS ≥ 36mmHg. Nustatyta, kad mažų iki 3mm AAL kimšimas Cook spiralėmis gali sėkmingai konkuruoti su operaciniu gydymu. Rasta, kad aortos, tuščiųjų venų ir plaučių arterijos šakų balioninės plastikos efektas trumpalaikis, o gydymas stentais daug sėkmingesnis. Nustatyta, kad anomalinių įgimtų ir pooperacinių kraujagyslinių jungčių užkimšimas spiralėmis yra saugus ir efektyvus gydymo metodas.
APA, Harvard, Vancouver, ISO, and other styles
9

黃一偉 and Yat-wai Patrick Wong. "Review on the effect of Salviae Miltiorrhizae Bunge (Danshen) in the management of coronary heart diseases." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31969860.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

MacInnes, J. "Illness representations, treatment beliefs and the relationship to self-care in heart failure." Thesis, Canterbury Christ Church University, 2011. http://create.canterbury.ac.uk/10332/.

Full text
Abstract:
Purpose The purpose of this study was to explore the beliefs people with heart failure hold about their illness and its treatment and to determine any relationships between these beliefs and self-care using the Common Sense Model (CSM) of illness cognitions and behaviour as the theoretical framework (Leventhal et al, 1980). Methods Using a mixed methodology (Creswell and Plano Clark, 2007), findings from patient interviews were used to adapt the Revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al, 2002) and the Beliefs about Medicines Questionnaire (BMQ) (Horne et al, 1999) in order to make them illness-specific. A questionnaire assessing self-care was developed based on the European Heart Failure Self-care Behaviour Scale (EHFScBS) (Jaarsma et al, 2003), the interview findings and a nominal group technique with specialist heart failure nurses. These questionnaires were used to determine beliefs and the relationship to behaviour in a cross-sectional survey of 169 patients with heart failure. Results A number of statistically significant correlations were found between beliefs and self-care. Most notably, perceived medication knowledge (r = 0.51, p ≤ 0.01), beliefs about the necessity of medication (r = 0.45, p ≤ 0.01) and illness coherence (r = 0.39, p ≤ 0.01). Multiple regression analysis revealed that 46% of the variance in self-care could be explained by illness representations and treatment beliefs (Adj. R2 = 0.46, F = 9.93, p = 0.00). Three factors were significant predictors of self-care - medication knowledge (β = 0.319, p = 0.003), a belief in the illness having serious consequences (β = 0.258, p = 0.008) and the impact of medication use on lifestyle (β = -0.231, p = 0.03). Discussion The exploration of illness representations revealed a realistic picture of heart failure with a cluster of beliefs around a chronic illness with serious consequences and a high number of symptoms. There was a strong belief in the necessity of medication but for some, medication use had a negative impact on daily life. Patients were confident in their knowledge of medication but this was reduced when family members took control of medication management. A number of beliefs were predictive of self-care, suggesting that interventions designed to maximise these beliefs and correct any misconceptions may enhance self-care and potentially improve clinical outcomes in this population.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Heart Diseases Treatment Victoria"

1

1924-, Wheat Myron W., ed. Treatment of cardiac emergencies. 4th ed. St. Louis: Mosby, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

1924-, Wheat Myron W., ed. Treatment of cardiac emergencies. 5th ed. St. Louis: Mosby, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

L, Baughman Kenneth, and Baumgartner William A, eds. Treatment of advanced heart disease. New York: Taylor & Francis, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ross, D. N. Principles of cardiac diagnosis and treatment: A surgeon's guide. 2nd ed. London: Springer-Verlag, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Valvular heart disease. Dordrecht: Humana Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Harvey, Richard P., and Nadia Rosenthal. Heart development and regeneration. Amsterdam: Academic, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

The natural way with heart disease. Shaftesbury, Dorset: Element Inc., 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Goldberg, Burton. Alternative medicine guide to heart disease. Tiburon, Calif: Future Medicine Pub., 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Borland, Douglas M. The treatment of certain heart conditions by homoeopathy. New Delhi: Jain, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ornish, Dean. Dr. Dean Ornish'sprogramme for reversing heart disease: The only system scientifically proven to reverse heart disease without drugs or surgery. London: Century, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Heart Diseases Treatment Victoria"

1

Stulak, John M., and Hartzell V. Schaff. "Surgical Treatment of Atrial Fibrillation." In Electrical Diseases of the Heart, 561–75. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4978-1_36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Josephson, Mark E. "Introduction to Part IV: Treatment Modalities." In Electrical Diseases of the Heart, 497–99. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4978-1_32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tung, Patricia, and Peter J. Zimetbaum. "Non-surgical Treatment and Prevention of Atrial Fibrillation." In Electrical Diseases of the Heart, 543–59. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-4978-1_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bongiorni, Maria Grazia, and Francesca Menichetti. "Biventricular Pacing in Women for Heart Failure." In Percutaneous Treatment of Cardiovascular Diseases in Women, 189–201. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39611-8_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Miller, Henry S. "Exercise for Prevention and Treatment of Coronary Heart Disease." In Exercise for Preventing Common Diseases, 69–73. Tokyo: Springer Japan, 1999. http://dx.doi.org/10.1007/978-4-431-68511-1_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dipchand, Anne I. "Origins and Treatment of Right Ventricular Dysfunction After Heart Transplantation." In Congenital Diseases in the Right Heart, 197–205. London: Springer London, 2009. http://dx.doi.org/10.1007/978-1-84800-378-1_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Das, Surojeet. "Biofilm-Mediated Diseases of the Heart and Lungs." In Biofilms in Human Diseases: Treatment and Control, 137–49. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-30757-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cheatham, John P. "Treatment of RV Outflow Tract Dysfunction: New Valve Technologies." In Fetal and Hybrid Procedures in Congenital Heart Diseases, 361–66. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40088-4_43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Figulla, Hans R., and Alexander Lauten. "Future Perspectives of Catheter-Based Treatment in Valvular Heart Diseases." In Textbook of Catheter-Based Cardiovascular Interventions, 1807–16. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-55994-0_105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Guckenberger, Matthias, Leonie Rudofsky, and Nicolaus Andratschke. "FDG-PET Imaging for Advanced Radiotherapy Treatment of Non-Small-Cell Lung Cancer." In Diseases of the Chest and Heart 2015–2018, 177–82. Milano: Springer Milan, 2015. http://dx.doi.org/10.1007/978-88-470-5752-4_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Heart Diseases Treatment Victoria"

1

Haxhibeqiri-Karabdić, Ilirijana, Emir Kabil, and Haris Vranić. "ISCHAEMIC HEART DISEASE – SURGICAL TREATMENT AND POST-OPERATIVE COMPLICATIONS." In Acquired Heart Diseases. Academy of Sciences and Arts of Bosnia and Herzegovina, 2015. http://dx.doi.org/10.5644/pi2015-158-07.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sun, Yuechen. "Yangxin Soup's treatment progress of heart diseases." In 2011 International Conference on Human Health and Biomedical Engineering (HHBE). IEEE, 2011. http://dx.doi.org/10.1109/hhbe.2011.6028955.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Grinev, Sergey Aleksandrovich. "APPLICATION OF THE ILIZAROV METHOD IN THE TREATMENT OF HEART DISEASES." In Наука и социум. Новосибирск: Автономная некоммерческая организация дополнительного профессионального образования "Сибирский институт практической психологии, педагогики и социальной работы", 2020. http://dx.doi.org/10.38163/978-5-6043859-4-4_2020_54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yarmolchy, Y. A., T. S. Chikova, E. V. Emelianenko, and M. N. Piatkevich. "APPLICATION OF RESPIRATORY GATING SYSTEMS FOR DIAGNOSIS AND TREATMENT OF ONCOLOGICAL DISEASES." In SAKHAROV READINGS 2022: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2022. http://dx.doi.org/10.46646/sakh-2022-2-223-226.

Full text
Abstract:
Respiratory gating systems are successfully used for the diagnosis and treatment of oncological diseases. Their use increases the accuracy of radiation therapy, which is especially important when delivering high doses to cancerous tumors, as is the case with stereotactic radiation therapy. The use of respiratory gating systems systems in cooperation with CT allows you to more accurately determine the position of the tumor and outline its boundaries, which reduces the error in further treatment with radiation therapy. Respiratory gating systems are used in the treatment of tumors of the left breast, since their use reduces the dose load on the heart.
APA, Harvard, Vancouver, ISO, and other styles
5

Cox, Martijn A. J., Jeroen Kortsmit, Carlijn V. C. Bouten, and Frank P. T. Baaijens. "Tissue Engineered Heart Valves Develop Native-Like Collagen Architecture." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206236.

Full text
Abstract:
Over the last few years, research interest in tissue engineering as an alternative for current treatment and replacement strategies for cardiovascular and heart valve diseases has significantly increased. For a tissue engineered heart valve to be functional, it should be able to withstand the high pressures and flows that occur in vivo. Nature’s solution for this challenge can be found in the complex collagen fiber architecture of the native aortic valve (Fig. 1).
APA, Harvard, Vancouver, ISO, and other styles
6

Goubergrits, L., R. Mevert, P. Yevtushenko, J. Schaller, S. Meyer, E. Riesenkampff, and T. Kuehne. "Treatment of the Aortic Coarctation: Prediction of the Hemodynamic Impact." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14397.

Full text
Abstract:
Aortic coarctation (CoA) accounts for approximately 10% of congenital heart diseases 1. CoA causing high pressure gradient can be successfully treated surgical or catheter-based. Long-term results, however, revealed decreased life expectancy associated with abnormal hemodynamics 1. To develop a next-generation personalized diagnostic-prognostic tools allowing treatment optimization and thus to improve life expectance, the innovative combination of imaging science, biofluid mechanics, and computer modeling is necessary. Patient-specific computational fluid dynamics (CFD) models of the CoA based on MRI data were created to analyze pre- and post-treatment hemodynamics with a focus on pressure gradient.
APA, Harvard, Vancouver, ISO, and other styles
7

Tenhoff, Amanda C., Alex J. Deakyne, Tinen L. Iles, Shanti L. Narasimhan, Sameh M. Said, Massimo Griselli, and Paul A. Iaizzo. "Development of an Open-Access Library of Pediatric Congenital Heart Diseases and Treatments: A Tutorial on the Atlas of Human Cardiac Anatomy." In 2020 Design of Medical Devices Conference. American Society of Mechanical Engineers, 2020. http://dx.doi.org/10.1115/dmd2020-9064.

Full text
Abstract:
Abstract The major aim of this project is to construct a growing database of information regarding specific manifestations of congenital heart diseases (CHDs), subsequent treatments, clinical cases, and patient outcomes. This will include 3D models generated from clinical imaging of individual patient hearts and respective de-identified clinical case information — all of which will be incorporated onto the free-access Atlas of Human Cardiac Anatomy website (http://www.vhlab.umn.edu/atlas/), where anyone can learn more about these diseases and their complexities [1]. Generated models can also be used for 3D printing, such as for pre-surgical planning, as well as for incorporation into virtual reality in order to expand outreach and education efforts [2]. Future work will incorporate computational modeling to enhance insights relative to treatment strategies and surgical planning. By studying a broad range of these unique individual cases, it will be possible for patients, clinicians, and medical device designers alike to better understand the clinical presentations of congenital heart diseases and develop more effective treatment strategies.
APA, Harvard, Vancouver, ISO, and other styles
8

Egorova, Irina A., Andrey E. Chervotok, Artyom V. Dyupin, Natalya V. Trejmut, and Pavel E. Pechorin. "Osteopathic treatment effectiveness evaluation of astheno-neurotic syndrome in post-COVID patients." In Innovations in Medical Science and Education. Dela Press Publishing House, 2022. http://dx.doi.org/10.56199/dpcsms.sjjq1180.

Full text
Abstract:
The article highlights the materials from the research of the effectiveness of osteopathic treatment of patients with astheno-neurotic syndrome with post-COVID syndrome. The study involved 40 patients of both sexes aged between 35 and 65. Patients with chronic lung diseases, severe heart failure, and anemic syndrome were excluded. The osteopathic status, level of asthenia, level of life quality, status of the autonomic nervous system were assessed. The main group received osteopathic treatment, whereas the comparison group was observed without conducting treatment. It was determined that against osteopathic treatment in patients of the main group, there was an improvement in the craniosacral mechanism parameters, a lower degree of incidence of major complaints; a normalized vegetative status; reduced signs of astheno-neurotic syndrome, and an improved life quality. The effectiveness of the therapeutic measures allows recommending the inclusion of osteopathic treatment in rehabilitation treatment of patients with post-COVID syndrome.
APA, Harvard, Vancouver, ISO, and other styles
9

Cox, Martijn A. J., Jeroen Kortsmit, Niels J. B. Driessen, Carlijn V. C. Bouten, and Frank P. T. Baaijens. "Inverse Mechanical Characterization of Tissue Engineered Heart Valves." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-192521.

Full text
Abstract:
Over the last few years, research interest in tissue engineering as an alternative for current treatment and replacement strategies for cardiovascular and heart valve diseases has significantly increased. In vitro mechanical conditioning is an essential tool for engineering strong implantable tissues [1]. Detailed knowledge of the mechanical properties of the native tissue as well as the properties of the developing engineered constructs is vital for a better understanding and control of the mechanical conditioning process. The nonlinear and anisotropic behavior of soft tissues puts high demands on their mechanical characterization. Current standards in mechanical testing of soft tissues include (multiaxial) tensile testing and indentation tests. Uniaxial tensile tests do not provide sufficient information for characterizing the full anisotropic material behavior, while biaxial tensile tests are difficult to perform, and boundary effects limit the test region to a small central portion of the tissue. In addition, characterization of the local tissue properties from a tensile test is non-trivial. Indentation tests may be used to overcome some of these limitations. Indentation tests are easy to perform and when indenter size is small relative to the tissue dimensions, local characterization is possible. We have demonstrated that by recording deformation gradients and indentation force during a spherical indentation test the anisotropic mechanical behavior of engineered cardiovascular constructs can be characterized [2]. In the current study this combined numerical-experimental approach is used on Tissue Engineered Heart Valves (TEHV).
APA, Harvard, Vancouver, ISO, and other styles
10

Sathyamoorthy, Mohan. "Two Dimensional Finite Element Analysis of Myocardial Infarction in the Human Left Ventricle." In ASME 1997 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 1997. http://dx.doi.org/10.1115/imece1997-0199.

Full text
Abstract:
Abstract Diseases of the heart and blood vessels are the number one causes of patient mortality in the United States. Of these conditions, myocardial infarctions, more commonly known as heart attacks, are the most feared of cardiovascular pathologies. The American Heart Association has dedicated billions of dollars over the past four decades to basic science and clinical research to help prevent and treat heart attacks. Detailed assessment of three dimensional stress, strain, and deformation histories is important because it has been noted that reduced transmural strain and left ventricular torsion may be indicative of myocardial infarction resulting from ischemia [1]. Previous studies have been limited to clinical and experimental modalities of study. With the evolution of high speed computers and finite element softwares, detailed and effective biomechanical modeling of complex physiological systems such as the heart have been undertaken. The objective of this study is to utilize finite element analysis to assess local and global deformation and stress patterns in normal vs. imposed conditions of myocardial infarction. Such knowledge obtained a priori could be utilized by cardiothoracic surgeons and cardiologists to improve the efficacy of treatment and treatment options for patients suffering from heart disease.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Heart Diseases Treatment Victoria"

1

Liu, Mengnan, Raoqiong Wang, Ziyi Li, Maryam Mazhar, Gang Luo, and Sijin Yang. Danshen decoction in the treatment of heart failure: a systematic review and meta-analysis protocol of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0107.

Full text
Abstract:
Review question / Objective: HF (heart failure) is considered to be the clinical endpoint and the leading cause of death of CVD (cardiovascular diseases). With people's growing desire for a healthy and better life, TCM (traditional Chinese medicine) as an alternative in the prevention and treatment of HF is becoming more popular. The basic and clinical research related to TCM has also been widely concerned by the cardiovascular community of scientists/clinicians. In recent years, a large number of preclinical (in vivo/in vitro) experiments and clinical observation studies have proved the therapeutic efficacy of Danshen decoction in the treatment of HF. However, systematic evaluation and review of the clinical treatment of Danshen decoction is insufficient, leaving objective and quantitative evaluation indicators of Danshen decoction to be inadequate. Therefore, evidence-based studies are urgently needed to demonstrate its efficacy and safety.
APA, Harvard, Vancouver, ISO, and other styles
2

FEDOTKINA, S. A., O. V. MUZALEVA, and E. V. KHUGAEVA. RETROSPECTIVE ANALYSIS OF THE USE OF TELEMEDICINE TECHNOLOGIES FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF HYPERTENSION. Science and Innovation Center Publishing House, 2021. http://dx.doi.org/10.12731/978-0-615-67320-2-4-22.

Full text
Abstract:
Introduction. The economic losses associated with disability due to diseases of the circulatory system, as well as the costs of providing medical care to patients suffering from heart and vascular diseases, are increasing annually. The state preventive measures currently being carried out are of a delayed nature. The results of the medical examination of the population of the Russian Federation in recent years (2015-2019) indicate that the incidence of cardiovascular diseases, including hypertension, is at a fairly high level. In the middle of the last century, the Concept of risk factors for the development of chronic non-communicable diseases were formulated, in the structure of which cardiovascular diseases, including arterial hypertension, occupies one of the primary positions. The concept is based on the results of promising epidemiological studies, and, at present, is a methodological basis for planning and organizing primary prevention of cardiovascular diseases. The purpose of the study. Based on the analysis of literary sources (including foreign ones) containing experience in the use of telemedicine technologies, to assess their significance for the prevention, diagnosis and treatment of hypertension, as well as forecasting improvements in the quality of medical care when adapting to the use of clinical recommendations. Materials and methods. The article provides an analytical review of the use of modern telemedicine technologies in the prevention of hypertension. The results of the study and their discussion. The analysis of literary sources has shown that in the context of the progress of information and telecommunication technologies in the healthcare system, a fundamentally new direction has appeared in the organization and provision of medical care to the population - telemedicine, which will ensure the modern level of prevention, detection and treatment of chronic non-communicable diseases, and also determines positive medical, social and economic performance indicators. To date, updates in the legislative framework of the Russian Federation are aimed at ensuring that medical care with the use of telemedicine technologies is more widespread, taking into account the standards of medical care and clinical recommendations. Conclusion. Based on a review of literature sources, it has been established that the modern solution to the problem of improving the quality of medical care for patients, including those with hypertension, diseases is medical care using telemedicine technologies that prove their medical, social and economic effectiveness.
APA, Harvard, Vancouver, ISO, and other styles
3

Weng, JIeqiong, Jingfang Zhang, Ke Xu, Mengfei Yuan, Tingting Yao, Xinyu Wang, and Xiaoxu Shen. Efficacy of Shexiang Baoxin Pills Combined with Statins on Blood Lipid Profile in Patients with Coronary Heart Disease: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0100.

Full text
Abstract:
Review question / Objective: P（Population) ：Patients with coronary heart disease; I（Intervention) : Statins treatment in combination with Shexiang Baoxin pill; C（Comparison): Statins alone; O（Outcome）: Improvement of symptoms and blood lipids; S（Study design）：Clinical randomized trials. Eligibility criteria: To be included, trials were required to meet the following criteria: (1) patients were included in the studies according to diagnostic criteria of coronary heart disease established by the WHO, InternationalSociety of Cardiology and Association (ISCA), Internal Medicine, 7th edition ( IM-7th), Practice of InternalMedicine, 14th edition ( PIM-14th), Guidelines for the Diagnosis of Cardiovascular Diseases in InternalMedicine, 3rd edition (GIM-3rd) or conventional diagnostic criteria (CDC) including assessment of anginapectoris and electrocardiogram (ECG) results; (2) the study was conducted as a randomized controlled trial.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Heart Diseases Treatment Victoria' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography